跳至主要内容
临床试验/CTRI/2025/10/095799
CTRI/2025/10/095799尚未招募Phase 3 4

Impact of reversal of neuromuscular blockade with Sugammadex vs Neostigmine on early postoperative respiratory muscle function in geriatric population

Himalayan Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年10月30日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
100
试验地点
1
主要终点
To compare postoperative Pulmonary function after neuromuscular blockade reversal associated with the use of Sugammadex and Neostigmine

研究概览

简要总结

This study is a comparative observational analysis evaluating the effectiveness of Sugammadex versus Neostigmine in reversing Vecuronium-induced neuromuscular blockade in patients aged over 65 years undergoing surgery under general anaesthesia. It aims to assess postoperative pulmonary function and residual blockade using spirometry, train-of-four monitoring, and diaphragm ultrasonography up to two hours postoperatively.

The study includes 100 patients, divided equally into two groups receiving either Sugammadex 2 mg/kg or Neostigmine 0.05 mg/kg with glycopyrrolate. Parameters such as inspiratory volume, TOF ratio, diaphragm contractility, and clinical recovery indicators are measured at set intervals post-reversal. The goal is to determine which agent ensures faster and more complete recovery with fewer respiratory complications, especially in the elderly.

研究设计

研究类型
Observational

入排标准

年龄范围
65.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • American Society of Anaesthesiologist Physical Status I-III
  • Scheduled for a surgical procedure under general anaesthesia requiring endotracheal intubation
  • Anaesthesia induction with Vecuronium as NMBA.

排除标准

  • Anticipation of a difficult airway
  • Known or suspected neuromuscular disorders, significant renal dysfunction, known or suspected family history of malignant hyperthermia, and allergies to narcotics, muscle relaxants, or other medications used during general anaesthesia
  • Patients receiving medication at a dose and/or time-point likely to interfere with NMBDs and in whom the use of Neostigmine and/or glycopyrrolate could be contraindicated
  • Those with diaphragm insufficiency or massive pleural effusion
  • Those undergoing upper abdominal laparotomy will be excluded after which we cannot obtain a satisfactory ultrasound imaging or do not have space for the placement of the ultrasound probe.

结局指标

主要结局

To compare postoperative Pulmonary function after neuromuscular blockade reversal associated with the use of Sugammadex and Neostigmine

时间窗: 10,30,60 and 120 minutes

次要结局

  • To evaluate the residual neuromuscular blockade effect of Vecuronium after reversal with Sugammadex compared to Neostigmine up to 2 hours postoperatively.(10,30,60 and 120 minutes)

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Amriish Garg

Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun

研究点 (1)

Loading locations...

相似试验